Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on 10 Freeway at Mountain Avenue


3 Vehicles Involved in Fatal Upland Accident 

Fatal Accident 3
Fatal Accident 3

Upland, CA (November 13, 2019) – One person was killed in a multi-vehicle crash in Upland. The fatal accident occurred on the morning of November 13 on the 10 Freeway.

Three vehicles – a Nissan Rogue, a big rig and another vehicle – collided on the eastbound 10 Freeway, at Mountain Avenue. The cause of the crash is unknown. One person died at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Upland

#91784


February 13, 2020

Woman Killed in Head-on Crash on Hills Ferry Road

Car, Big Rig Collide in Fatal Newman Accident...


December 3, 2019

Man Injured After Crashing Into Yard on Amestoy Avenue

Police Pursuit Leads to DUI Accident in Van Nuys...


May 6, 2020

2 Injured in Crash on Highway 50 Near Howe Avenue

Davvonae Brown Arrested for DUI in Sacramento Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.